Singh Sanjay R 4

4 · MANNKIND CORP · Filed Mar 25, 2026

AI-generated summary of this filing

Updated Mar 26, 2026

MannKind (MNKD) EVP Sanjay R. Singh Receives RSU Awards

What Happened

Sanjay R. Singh, Executive Vice President, Technical Operations at MannKind, received two restricted stock unit (RSU) awards on 2026-03-23 totaling 438,000 RSUs (221,000 and 217,000). Each RSU is a contingent right to one share of MNKD common stock and the awards were granted at a $0.00 purchase price (derivative awards, no cash exchanged).

Key Details

Transaction date: March 23, 2026; Form 4 filed March 25, 2026 (timely within the usual two-business-day window).
Award amounts: 221,000 RSUs and 217,000 RSUs (total 438,000 RSUs); grant price reported as $0.00.
Shares owned after transaction: not specified in the provided filing excerpt.
Footnotes: F1 — each RSU converts to one share if/when vested; F2 — one award is performance-based, vests (if earned) on Jan 15, 2029 with payout 0%–300% of target based on MannKind total shareholder return vs. the Russell 3000 Pharmaceutical & Biotechnology Index for Apr 1, 2026–Dec 31, 2028; F3 — the other award follows time-based vesting (25% vests Mar 23, 2027, then 1/16th quarterly thereafter).
No tax-withholding or sale-on-vesting details were reported in the excerpt.

Context

These are grants of RSUs (derivative awards), not open-market purchases or sales. RSUs do not represent immediate ownership of shares until they vest and may be forfeited if vesting conditions are not met. The performance-based RSU can pay out between 0% and 300% of target depending on relative TSR performance; the time-based RSU vests over several quarters beginning March 23, 2027.

Form 4

Period: 2026-03-23

EVP Technical Operations

Transactions

Award
Performance Restricted Stock Unit
[F1][F2]
2026-03-23+221,000→ 221,000 total
→ Common Stock, $0.01 Par Value (221,000 underlying)
Award
Employee Stock Option (right to buy)
[F3]
2026-03-23+217,000→ 217,000 total
Exercise: $2.44From: 2027-03-23Exp: 2036-03-23→ Common Stock, $0.01 Par Value (217,000 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
[F2]The performance-based restricted stock unit will vest on January 15, 2029. The number of shares delivered on the vesting date, as a percentage of the target specified [in Box 5 above], is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from April 1, 2026 until December 31, 2028 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the measurement period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above.
[F3]25% vesting on March 23, 2027 and thereafter 1/16th quarterly.

Signature

/s/ Sanjay R Singh|2026-03-25

1 file